Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More
Briefly

Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More
"TD Cowen reduced estimates across the household and personal care space, arguing that companies will be unable to fully mitigate higher oil-related input costs stemming from the Iran war."
"Even a swift resolution to the conflict won't reverse the damage - price increases will prove sticky due to infrastructure damage."
"P&G's premiumization strategy has been a key margin lever, but if consumers are already stretched, moving them toward higher-priced SKUs becomes structurally harder."
"Core EPS came in at $1.88, beating the consensus estimate of $1.8569, but net sales of $22.21 billion missed the $22.29 billion estimate."
Procter & Gamble's price target was cut by TD Cowen from $156 to $142, maintaining a Hold rating. The firm cites oil-related input cost inflation linked to the Iran war as a significant challenge. P&G's shares have seen limited upside, with a 2.07% increase this year after an 11.49% decline last month. The company's premiumization strategy is under pressure as consumers face financial constraints, impacting pricing power and margins. Q2 FY2026 results showed a decline in net sales and operating income, highlighting the challenges ahead.
Read at 24/7 Wall St.
Unable to calculate read time
[
|
]